The introduction to Cancer Cytopathology’s inaugural Supplement (Volume 125/Issue 6/June 2017) leads with the concept that cytopathology is the nexus for patient-centered care. The convergence of minimally invasive diagnostic and therapeutic techniques, refinements in imaging and guided biopsies, molecular testing and whole genome sequencing, the emergence of targeted therapies, and the awakening of pathologists to their critical role in patient care, safety and outcomes have created a new force in medicine: pathologists are critical members of the health care team and patients are at the center of their concerns and efforts.
Immersive Cytopathology Experience (ICE) has been redesigned for presentation at a fabulous venue in Reykjavik, Iceland, combining concepts from Diagnostic Cytopathology and classical ICE (a hands-on learning experience at the USCAP Interactive Learning Center). There is monumental value in case-based learning that simulates multidisciplinary collaborative interaction of hospital-based tumor boards. This program is highlighted by the interaction of interventional cytopathologists with a surgeon, exemplary patient, and challenging cases from academic institutions, focusing on head and neck clinical lesions.
Classification schemes, the molecular and genetic basis of head and neck disease, procedural approaches to specimen acquisition and processing, empathetic communication, quality and patient safety, and measuring the non-clinical performance of the academic pathologist contribute texture and depth to this learning experience.
The schedule accommodates time for you to experience ICELAND, from The Blue Lagoon to the Northern Lights and locations where Game of Thrones is filmed.
USCAP is transforming how we learn and where we learn. From a 15th century convent in Florence to the Harpa Concert Hall and Conference Centre in Iceland, learners “come from away” for their unique and enduring experience.
• Utilize an exemplary index case and several expository cases from academic centers to
understand relevant clinicopathologic diagnostic and therapeutic aspects of
head and neck diseases
• Understand morphologic, molecular, genetic and cytologic features of selected head and neck
tumors and how they are classified
• Refine skills for interaction with patients and clinicians, including empathetic communication
and how the ideal interactive health care team operates
• Explore how to optimize quality and patient safety with principals of root cause analysis,
systems improvements, error reporting, disclosure and apology and scenario role play
• Learn interventional skills related to ultrasound-guided fine needle aspiration biopsy,
rapid on site evaluation (ROSE) and optimal specimen preparation and triage. Hands-on access is
restricted to the first 25 registrants who express interest in this activity.
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The United States and Canadian Academy of Pathology designates this live activity for a maximum of 24.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
USCAP is approved by the American Board of Pathology (ABP) to offer Self-Assessment credits (SAMs) for the purpose of meeting the ABP requirements for Continuing Certification.
Physicians can earn a maximum of 24.75 SAM credit hours.